Expression regulation by a methyl-CpG binding domain in an E. coli based, cell-free TX-TL system

Area of Science:

• Epigenetics
• Molecular Biology
• Structural Biology

Background:

• Cytosine methylation is crucial for eukaryotic gene expression regulation.
• Methyl-CpG binding domains (MBDs) are key components of transcriptional regulators.
• The precise mechanism of MBD sequence and methylation-dependent CpG recognition is not fully understood.

Purpose of the Study:

• To investigate the sequence and methylation-dependent binding of the MBD from human MeCP2 to the BDNF promoter.
• To explore the functional role of MBD in transcriptional repression using a prokaryotic system.
• To elucidate the structural basis of MBD-DNA interaction and its impact on DNA conformation.

Main Methods:

• Escherichia coli cell-free expression system for MBD production.
• Experimental analysis of MBD binding and repression activity on the BDNF promoter.
• Molecular dynamics simulations to study DNA conformational changes upon MBD binding.

Main Results:

• Human MeCP2 MBD functions as a specific, methylation-dependent repressor of the BDNF promoter in a cell-free system.
• Mutations flanking the CpG site affect target gene expression levels but not the MBD concentration-dependent repression.
• Molecular dynamics simulations reveal cooperative DNA transitions upon MBD binding, correlating with experimental data.

Conclusions:

• MBD-mediated repression involves not only steric hindrance but also MBD-induced conformational changes in the promoter DNA.
• Prokaryotic transcription systems can recapitulate key features of mammalian epigenetic regulatory elements.
• This study provides insights into the molecular mechanisms of MBD-mediated gene silencing.